[Myocardial remodeling in pediatric congenital cardiac diseases]

Insights

Pediatric congenital heart disease causes myocardial remodeling via inflammation and stress signaling. Hypoxemia in these infants may impair protective growth signals, increasing cardiac dysfunction.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Pediatrics

Background:

  • Myocardial remodeling in pediatric congenital heart diseases contributes to dysfunction, morbidity, and mortality.
  • This remodeling involves complex inflammatory, growth, and cell death signaling pathways.

Purpose of the Study:

  • To investigate the molecular mechanisms of myocardial remodeling in infants with right ventricular pressure overload and hypoxemia.
  • To elucidate the roles of specific signaling pathways, including p38MAPK, HIF-1, and JAK/STAT, in response to hemodynamic stress and hypoxemia.

Main Methods:

  • Analysis of myocardial tissue and signaling pathways in infants with right ventricular pressure overload.
  • Assessment of pro-inflammatory cytokine expression (TNF-α, IL-1β, IL-6) and activation of p38MAPK signaling.
  • Evaluation of hypoxia-inducible factor 1 (HIF-1) activation and its downstream targets (VEGF, eNOS) and growth signaling (CT-1) via JAK/STAT pathway.

Main Results:

  • Right ventricular pressure overload induces pro-inflammatory cytokine expression via p38MAPK activation.
  • Hypoxemia activates HIF-1, leading to VEGF and eNOS induction, potentially as an adaptive response.
  • Hypoxemia also stimulates CT-1 via JAK/STAT, but increased troponin T degradation suggests impaired protective function in cyanotic infants.

Conclusions:

  • Mechanical stress and hypoxemia differentially regulate inflammatory and growth signaling in pediatric congenital heart disease.
  • Hypoxemia's dual role in potentially adaptive responses and impaired myocardial protection warrants further investigation.
  • Understanding these pathways is crucial for managing myocardial remodeling and improving outcomes in affected children.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
793
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
711
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
803
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
856
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
909